Amid Wegovy and Ozempic boom, Novo eyes new facility with 200-acre land buy in Denmark

After making major manufacturing outlays in places like China and the United States earlier this year, Novo Nordisk is returning to its Danish roots.

Earlier this month, Novo Nordisk purchased a 200-acre site in Odense, Denmark’s third largest city, Reuters first reported. The company is now set to kick off preparatory excavation work for a potential new production plant, the news service said.